Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma

James K. Godfrey, Lei Gao, Geoffrey Shouse, Joo Y. Song, Stacy Pak, Brian Lee, Bihong T. Chen, Avyakta Kallam, John H. Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V. Danilov, Alex F. Herrera, Larry W. Kwak, Lihua E. Budde

Blood (2024) 144 (4): 457–461.

https://doi.org/10.1182/blood.2024024168

Published: 2024

Includes: Supplemental data

Journal Articles

A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease

Blood (2023) 142 (Supplement 1): 3556.

https://doi.org/10.1182/blood-2023-189104

Published: 2023

Journal Articles

Effect of Pre-Transplantation Nutritional Status on the Early Related Complications of Allogeneic Hematopoietic Stem Cell Transplantation:a Cohort Study

Fangfang Wu, Shanshan Du, Xin Du, Rufu Xu, Aihua Sun, Peiyan Kong, Lei Gao, Xi Zhang

Blood (2023) 142 (Supplement 1): 5103.

https://doi.org/10.1182/blood-2023-188646

Published: 2023

Journal Articles

Application Gene Variation Detection before and after Hematopoietic Stem Cell Transplantation to Predict the Relapse of Hematopoietic Neoplasm Patients after Transplantation: Retrospective Data from a Single Center in China

Jia Liu, Peiyan Kong, Lidan Zhu, Shichun Gao, Lu Wang, Huanfeng Liu, Ting Chen, Yimei Feng, Yuqing Liu, Lei Gao, Xi Zhang

Blood (2023) 142 (Supplement 1): 6975.

https://doi.org/10.1182/blood-2023-188458

Published: 2023

Journal Articles

Efficacy and Safety of Hetrombopag in Promoting Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial

Yimei Feng, Linhui Wang, Tao Lang, Mingqiang Ren, Hai Yi, Jianchuan Deng, Liangliang Ma, Hongyun Xing, Dan Wang, Han Yao, Ting Chen, Yuqing Liu, Lidan Zhu, Jia Liu, Shichun Gao, Lei Gao, Xi Zhang

Blood (2023) 142 (Supplement 1): 3539.

https://doi.org/10.1182/blood-2023-188481

Published: 2023

Journal Articles

Efficacy and Safety of Herombopag for the Treatment of Secondary Failure of Platelet Recovery after Allogeneic Hematopoietic Stem Cell Transplantation: The Single Center Prospective Study from China

Huanfeng Liu, Lidan Zhu, Jia Liu, Shichun Gao, Lu Wang, Peiyan Kong, Ting Chen, Yimei Feng, Yuqing Liu, Lei Gao, Xi Zhang

Blood (2023) 142 (Supplement 1): 6967.

https://doi.org/10.1182/blood-2023-188407

Published: 2023

Journal Articles

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Blood (2023) 142 (16): 1359–1370.

https://doi.org/10.1182/blood.2023020485

Published: 2023

Includes: Supplemental data

Journal Articles

Efficiency and Toxicity of Imatinib Mesylate Combined with Atorvastatin Calcium for Steroid-Refractory Chronic Graft-Versus-Host Disease

Ting Chen, Han Yao, Yuqing Liu, Lidan Zhu, Jia Liu, Liu Huanfeng, Shichun Gao, Lu Wang, Lu Zhao, Yimei Feng, Lei Gao, Xi Zhang, Peiyan Kong

Blood (2022) 140 (Supplement 1): 4784–4785.

https://doi.org/10.1182/blood-2022-169673

Published: 2022

Journal Articles

Phase II Multicenter, Randomized Controlled Study on Infusion of MSCs at 45 Days after Haplo-Hematopoietic Stem Cell Transplantation in the Prophylaxis of Gvhd

Ruihao Huang, Ting Chen, Sanbin Wang, Jishi Wang, Yi Su, Jing Liu, Peiyan Kong, Cheng Zhang, Lei Gao, Li Gao, Xi Zhang

Blood (2022) 140 (Supplement 1): 7651–7652.

https://doi.org/10.1182/blood-2022-169431

Published: 2022

Journal Articles

Decitabine Combined with FB3 As Conditional Regimen for Elderly/Weak Acute Myeloid Leukemia Patient with Allo-HSCT

Shichun Gao, Peiyan Kong, Lidan Zhu, Jia Liu, Liu Huanfeng, Lu Wang, Cheng Zhang, Li Gao, Lei Gao, Xi Zhang

Blood (2022) 140 (Supplement 1): 12835–12836.

https://doi.org/10.1182/blood-2022-169384

Published: 2022

Journal Articles

Efficacy and Safety of Azacytidine Combined with Low-Dose Lenalidomide in Preemptive Treatment of Post Allo-SCT Acute Myeloid Leukemia Patients with Detectable Minimal Residual Disease

Lu Wang, Yimei Feng, Lei Gao, Peiyan Kong, Xi Zhang

Blood (2022) 140 (Supplement 1): 12933.

https://doi.org/10.1182/blood-2022-168641

Published: 2022

Journal Articles

Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I Trial

Ruihao Huang, Qin Wen, Xiaoqi Wang, Hongju Yan, Yingying Ma, Wang Mai-Hong, Xiao Han, Li Gao, Lei Gao, Cheng Zhang, Xi Zhang

Blood (2022) 140 (Supplement 1): 7450–7451.

https://doi.org/10.1182/blood-2022-170712

Published: 2022

Journal Articles

Combination Azacitidine and Lenalidomide: A Novel Relapse Prophylaxis Option in Patients after Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia

Yimei Feng, Lu Wang, Ting Chen, Han Yao, Yun Zhang, Yuqing Liu, Lu Zhao, Lei Gao, Peiyan Kong, Xi Zhang

Blood (2022) 140 (Supplement 1): 4894.

https://doi.org/10.1182/blood-2022-169465

Published: 2022

Journal Articles

CD19-Directed Fast CART Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia: From Bench to Bedside

Cheng Zhang, Jiaping He, Li Liu, Jishi Wang, PhD, Sanbin Wang, Ligen Liu, Lei Gao, Li Gao, Yao Liu, Peiyan Kong, Jia Liu, Yu Han, Yongliang Zhang, Zhe Sun, Xun Ye, Yan He, Lianjun Shen, MD PhD, Wei Cao, Xi Zhang

Blood (2019) 134 (Supplement_1): 1340.

https://doi.org/10.1182/blood-2019-128006

Published: 2019

Journal Articles

Effective Novel Fto Inhibitors Show Potent Anti-Cancer Efficacy and Suppress Drug Resistance

Blood (2019) 134 (Supplement_1): 233.

https://doi.org/10.1182/blood-2019-124535

Published: 2019

Journal Articles

Role of Donor-Derived CD19.CAR-T Cells in Treating Patients That Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation

Cheng Zhang, MD PhD, Lei Gao, Yao Liu, Li Gao, Pei-Yan Kong, Jun Liu, Ruihao Huang, Ying-Ying Ma, Defu Zeng, MD PhD, Qing-Hui Xiong, Wei-Ling Mei, Jia Liu, Peng-Fei Jiang, Xun Ye, De-Ping Han, Wei Cao, Xi Zhang

Blood (2019) 134 (Supplement_1): 4561.

https://doi.org/10.1182/blood-2019-128262

Published: 2019

Journal Articles

A Bcma and CD19 Bispecific CAR-T for Relapsed and Refractory Multiple Myeloma

Hua Zhang, Lei Gao, Li Liu, Jishi Wang, PhD, Sanbin Wang, Li Gao, Cheng Zhang, MD PhD, Yao Liu, Peiyan Kong, Jia Liu, Jiaping He, Yu Han, Hua Shi, Yan He, Xun Ye, Yi Zhao, Wei Cao, Lianjun Shen, Xi Zhang

Blood (2019) 134 (Supplement_1): 3147.

https://doi.org/10.1182/blood-2019-131056

Published: 2019

Journal Articles

Efficacy of Low-Dose Decitabine in the Early Relapse of AML/MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Xu Guo-Fa, Chen Ting, Liu Huanfeng, Lin Shijia, Lei Gao, Cheng Zhang, MD PhD, Yao Liu, Xi Zhang, Defu Zeng, MD, Kong Peiyan

Blood (2018) 132 (Supplement 1): 5739.

https://doi.org/10.1182/blood-2018-99-115659

Published: 2018

Journal Articles

Decitabine Combined with FB3 As Conditional Regimen for Elderly Acute Myeloid Leukemia Patient with Allogeneic Hematopoietic Stem Cell Transplantation

Shichun Gao, Jia Liu, Kong Peiyan, Li Gao, Cheng Zhang, MD PhD, Yao Liu, Hongju Yan, Lidan Zhu, Defu Zeng, MD, Lei Gao, Xi Zhang

Blood (2018) 132 (Supplement 1): 2108.

https://doi.org/10.1182/blood-2018-99-115926

Published: 2018

Journal Articles

Updated Results from a Phase Ib Study of Isatuximab Plus Pomalidomide (Pom) and Dexamethasone (dex) in Relapsed/Refractory Multiple Myeloma (RRMM)

Paul G Richardson, MD, Joseph Mikhael, MD, Saad Z Usmani, MD, Noopur Raje, MD, William Bensinger, MD, Dheepak Kanagavel, MD PhD, Lei Gao, Samira Ziti-Ljajic, Kenneth C Anderson, MD

Blood (2017) 130 (Supplement 1): 1887.

https://doi.org/10.1182/blood.V130.Suppl_1.1887.1887

Published: 2017

NARROW

Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma

A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease

Effect of Pre-Transplantation Nutritional Status on the Early Related Complications of Allogeneic Hematopoietic Stem Cell Transplantation:a Cohort Study

Application Gene Variation Detection before and after Hematopoietic Stem Cell Transplantation to Predict the Relapse of Hematopoietic Neoplasm Patients after Transplantation: Retrospective Data from a Single Center in China

Efficacy and Safety of Hetrombopag in Promoting Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial

Efficacy and Safety of Herombopag for the Treatment of Secondary Failure of Platelet Recovery after Allogeneic Hematopoietic Stem Cell Transplantation: The Single Center Prospective Study from China

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Efficiency and Toxicity of Imatinib Mesylate Combined with Atorvastatin Calcium for Steroid-Refractory Chronic Graft-Versus-Host Disease

Phase II Multicenter, Randomized Controlled Study on Infusion of MSCs at 45 Days after Haplo-Hematopoietic Stem Cell Transplantation in the Prophylaxis of Gvhd

Decitabine Combined with FB3 As Conditional Regimen for Elderly/Weak Acute Myeloid Leukemia Patient with Allo-HSCT

Efficacy and Safety of Azacytidine Combined with Low-Dose Lenalidomide in Preemptive Treatment of Post Allo-SCT Acute Myeloid Leukemia Patients with Detectable Minimal Residual Disease

Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I Trial

Combination Azacitidine and Lenalidomide: A Novel Relapse Prophylaxis Option in Patients after Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia

CD19-Directed Fast CART Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia: From Bench to Bedside

Effective Novel Fto Inhibitors Show Potent Anti-Cancer Efficacy and Suppress Drug Resistance

Role of Donor-Derived CD19.CAR-T Cells in Treating Patients That Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation

A Bcma and CD19 Bispecific CAR-T for Relapsed and Refractory Multiple Myeloma

Efficacy of Low-Dose Decitabine in the Early Relapse of AML/MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Decitabine Combined with FB3 As Conditional Regimen for Elderly Acute Myeloid Leukemia Patient with Allogeneic Hematopoietic Stem Cell Transplantation

Updated Results from a Phase Ib Study of Isatuximab Plus Pomalidomide (Pom) and Dexamethasone (dex) in Relapsed/Refractory Multiple Myeloma (RRMM)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only